Parkinson hastalığının tedavisi olarak ketojenik bir diyetin karışık bir yöntem fizibilite çalışması.
A mixed methods feasibility study of a ketogenic diet as treatment for Parkinson's disease.
DOI: 10.3389/fnut.2025.1601446PMID: 40771211
A mixed methods feasibility study of a ketogenic diet as treatment for Parkinson's disease.
DOI: 10.3389/fnut.2025.1601446PMID: 40771211
Carbon-based nanotechnology for Parkinson's disease: diagnostic and therapeutic innovations.
DOI: 10.1080/17435889.2025.2535940PMID: 40697108
Decoding Parkinson's Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations.
DOI: 10.1016/j.redox.2025.103787PMID: 40712453
Targeting ASK1 signaling in neurodegeneration: molecular insights and therapeutic promise.
DOI: 10.1007/s10495-025-02148-3PMID: 40702249
Motor and Functional Improvement in a 71-Year-Old Parkinson’s Disease Patient Following a Series of Intravenous Nanobubble and Methylene Blue Therapy: A Case Report
DOI: 10.20944/preprints202507.1803.v1
The role of autophagy in the pathogenesis and treatment of multiple sclerosis.
DOI: 10.1080/27694127.2025.2529196PMID: 40717814
<i>TREM2</i> in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting.
DOI: 10.3390/ijms26157057PMID: 40806186
Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis.
DOI: 10.1007/s10787-025-01846-3PMID: 40694206
Therapeutic Potential of Standardized Acalypha indica Extract in MPTP-Induced Parkinsonism in Mice.
DOI: 10.1002/cbdv.202501226PMID: 40694653
Nanomaterials engineered for photothermal therapy in neural tumors and neurodegenerative diseases: biomaterial design, clinical mechanisms and applications.
DOI: 10.3389/fbioe.2025.1631627PMID: 40761545
Asleep versus awake deep brain stimulation in the treatment of Parkinson disease: a systematic review and meta-analysis.
DOI: 10.1007/s00415-025-13264-0PMID: 40690042
Branched-Chain Amino Acids in Parkinson's Disease: Molecular Mechanisms and Therapeutic Potential.
DOI: 10.3390/ijms26146992PMID: 40725241
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.